Objective. Epithelioid glioblastoma is a rare morphologic subtype of glioblastoma that closely mimics metastatic carcinoma or metastatic melanoma histologically. All previous case reports of this unusual glioblastoma variant have been solitary lesions. We report here the irst case to our knowledge of multifocal epithelioid glioblastoma mimicking cerebral metastasis.
Introduction
Epithelioid glioblastoma is a rare morphological subtype of glioblastoma 5, 8, 15, 16 . It has not yet been formally codiied in the World Health Organization (WHO) Classiication of Tumours of the Central Nervous System 9 . This glioblastoma variant can cause diagnostic confusion on several levels, including on preoperative imaging evalua-tion and on histopathologic examination. It closely mimics metastatic epithelioid carcinoma or amelanotic metastatic melanoma histologically. On imaging studies, many examples are supericial and well-circumscribed, mimicking metastatic carcinoma or meningioma. The potential for misinterpretation of the imaging studies and the histopathology is even more likely when this high-grade glioma presents as multifocal disease.
Case report
A 67-year-old, right-handed man with a past medical history signiicant for mycosis fungoides, a form of cutaneous T-cell lymphoma, was referred to the University of Texas M. D. Anderson Cancer Center after presenting with acute onset memory loss, dificulty inding words, and impaired peripheral vision. The patient denied any associated seizure activity or confusion. Initial brain computed tomography (CT) and MRI scans revealed two discrete brain lesions -one dominant lesion located in the left temporal lobe, and a second smaller lesion located in the left occipital lobe ( Fig 1A and 1B) . The neurological examination was signiicant for speech hesitancy, suggestive of a mild expressive aphasia, and right-sided homonymous hemianopsia on visual ield testing. No other focal neurological deicits were apparent. An extensive metastatic workup failed to reveal evidence of systemic malignancy.
As an adjunct to deinitive therapy, the patient received high-dose dexamethasone and experienced marked improvement of his symptoms. Two ipsilateral craniotomies were performed in a single intervention assisted by neuronavigation and ultrasonography. Intraoperatively, both lesions appeared well circumscribed and gross total resection of both was successfully achieved.
Histopathological examination revealed a high-grade epithelioid neoplasm comprised of variably-sized cells with abundant eosinophilic cytoplasm, rounded cell contours without ibrillary cytoplasmic processes, and nuclei that frequently displayed prominent single macronucleoli ( Fig. 2A ). The morphologic features were compatible with either metastatic epithelioid carcinoma or metastatic amelanotic melanoma. Subsequent immunohistochemical studies revealed lack of reactivity for both carcinoma markers (cytokeratins) and melanoma markers (HMB-45). Based on these negative results for metastatic neoplasm, additional immunohistochemical studies were then performed, which revealed strong cytoplasmic positivity for glial ibrillary acidic protein (GFAP; Fig. 2B ) and S-100 protein. The morphologic features combined with the immunophenotypic proile conirmed a histopathologic diagnosis of epithelioid glioblastoma, and, in conjunction with the preoperative imaging studies, a clinical diagnosis of multifocal epithelioid glioblastoma was rendered.
The patient had an uncomplicated postoperative course and was discharged from the hospital on postoperative day three without any neurological deicits. Postoperative MR imaging conirmed resection of the two contrast-enhancing lesions. The patient received adjuvant chemotherapy with low-dose temozolomide. Sixty Gray (Gy) in 30 fractions of intensity-modulated radiation therapy (IMRT) was deli-550-554 Figure 1 . A: preoperative gadolinium-enhanced T1-weighted axial MRI scan revealing a dominant lesion located in the left temporal lobe, demonstrating ring enhancement. B: preoperative gadolinium-enhanced T1-weighted axial MRI scan revealing a second smaller lesion located in the left occipital lobe, also demonstrating ring enhancement.
vered to the resection cavity; and 48 Gy in equivalent fractions was delivered to the surrounding brain parenchyma.
Discussion
Glioblastoma is remarkable for the diversity of morphological appearances that the constituent tumor cells can assume. In some tumors, a distinctive cell type may predominate, comprising 50% or more of the tumor. Two of the more common examples are small cell glioblastoma and giant cell glioblastoma 9 . Rarer forms include granular cell glioblastoma 17 , rhabdoid glioblastoma 6 , and signet-ring cell glioblastoma 10 . Of the various morphologic patterns that may be seen, epithelial differentiation is among the rarest, accounting for only 1.6% of all glioblastoma cases in one large series 15 . The various forms of epithelial differentiation in glioblastoma can be divided into pseudoepithelial patterns (adenoid and epithelioid) and true epithelial differentiation 15 . True epithelial differentiation is characterized not only by epithelial morphology but also by the expression of tissue-speciic epithelial markers, such as epithelial membrane antigen (EMA), low-molecular weight keratins (e.g., CAM5.2), and carcinoembryonic antigen (CEA). In contrast, pseudoepithelial differentiation consists only of epithelial-like morphology, without expression of speciic epithelial antigens; rather, the tumor cells forming the epithelial-like structures are usually at least partially reactive for glial markers (GFAP and S-100 protein). It should be noted in passing that cross-reactivity to broad spectrum cytokeratins, in particular cytokeratins AE1/AE3, is frequently seen in glioblastoma in general regardless of morphologic subtype and this well-recognized phenomenon does not constitute evidence of epithelial differentiation 13 .
True epithelial differentiation can assume the form of either squamous cell nests or glandular nests 11, 15 . Pseudoepithelial differentiation has two different forms: adenoid, with cohesive cell clusters arranged in cords, nests and/or a cribriform pattern, and epithelioid, in which the tumor cells are relatively large, round, have copious amounts of eosinophilic cytoplasm, generally lack cytoplasmic processes or are very process-poor, and often display large nuclei with single prominent nucleoli 1, 4, 5, 8, 12, 15 . Of these three major types of epithelial morphology, adenoid is the most common, followed by true epithelial differentiation, and with epithelioid glioblastoma being the rarest 15 . Sarcomatous metaplasia (gliosarcoma) is commonly seen in association with epithelial morphology, especially in adenoid glioblastoma, in which it is present in over 50% of cases 15 .
All forms of pseudoepithelial and true epithelial differentiation can be mistaken for metastatic carcinoma. Because the adenoid and true epithelial differentiation forms also typically have a more typical glial component, they may be mistaken for either a tumor-to-tumor metas- tasis or a collision tumor 12 . Epithelioid glioblastoma, in contrast, can be mistaken for metastatic epithelioid carcinoma or for metastatic amelanotic melanoma 5 . Some examples of epithelioid glioblastoma exhibit variable degrees of cytoplasmic lipid vacuoles, with this change prominently affecting a majority of tumor cells in about 10% of cases; such tumors have been referred to as "lipidized epithelioid glioblastoma" 15, 16 . Preliminary molecular genetic characterization of the three forms of glioblastoma with epithelial morphology has been performed 15 . The results show that most alterations are similar to those found in glioblastoma in general. Among the three forms, epithelioid glioblastoma is notable for the high percentage of cases exhibiting EGFR gene ampliication (50%) and strong EGFR immunopositivity (63%), compared to only 20% of adenoid glioblastomas and glioblastomas with true epithelial differentiation 15 .
The occurrence of multiple foci of glioblastoma has long been recognized and such instances have traditionally been categorized as either multifocal or multicentric, with multifocal glioblastoma exhibiting an obvious pathway of spread, such as through commissural pathways like the corpus callosum, fornix or massa intermedia, or by dissemination via the cerebrospinal pathways, and multicentric glioblastoma comprising truly independent, separate foci of gliomagenesis 2, 3 . Multifocal glioblastoma is monoclonal in origin, whereas multicentric glioblastoma would be postulated to arise from two separate clones. In practice, the imaging demonstration of a direct connection between two glioma epicenters in the form of T2-weighted or T2-FLAIR signal hyperintensity, as is seen in the present case, is taken as presumptive evidence of direct contiguous spread between the foci, and such cases are considered to be multifocal glioblastoma even in the absence of histologic or molecular genetic conirmation.
The diagnostic pitfall of multifocal or multicentric glioblastoma mimicking metastatic disease is well recognized 3, 14 . This potential for misinterpretation is even more likely for epithelioid glioblastoma because of its tendency to be relatively well-circumscribed and supericially located in the vicinity of the gray-white matter junction. In the present case, the patient's history of mycosis fungoides posed an additional complicating factor as mycosis fungoides involvement of the brain, although rare, is very well recognized 7, 18 .
Conclusion
Epithelioid glioblastoma is a very rare, but well documented, entity. Here we describe a case of multifocal epithelioid glioblastoma that convincingly mimicked a secondary metastatic process both on preoperative imaging studies and on histopathology. Multifocal epithelioid glioblastoma should be considered in the differential diagnosis of all patients who present with multiple brain lesions, even in the presence of a known primary systemic malignancy. An attempt at gross total resection is recommended for deinitive histopathologic diagnosis and to improve progression free survival of patients presenting with similarly ambiguous and potentially misleading multiple lesions.
